Mindfulness and Biofeedback for Anxiety Disorders

This randomized controlled trial compared the effectiveness of a 10-day mindfulness training program using adaptive biofeedback (BFB) versus medication therapy (escitalopram 10 mg/day) versus combined treatment (BFB + medication) in inpatients with anxiety disorders (ICD-10 F40/F41). The primary outcomes were changes in anxiety (Hamilton Anxiety Rating Scale, HARS) and mindfulness (Five Facet Mindfulness Questionnaire, FFMQ) from baseline to post-treatment and at one-month follow-up.

NCT Number	NCT07628153
Lead Sponsor	I.M. Sechenov First Moscow State Medical University
Conditions	Anxiety Disorders
Enrollment	188 participants
Start Date	2022-07-11
Primary Completion	2025-02-24 (estimated)
Study Completion	2025-02-24 (estimated)
Updated on ClinicalTrials.gov	2026-06-04